Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2017 Filed Dec 19, 2017 00:52 UTC
RIKER LAURENVice President, Finance
SaleCommon Stock 340 $43.70 $14,858.00
Disclosure

SEC source: 0001209191-17-066234 · doc4.xml · nonDerivative · entry 1

Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,442

F1 · balance_after: Includes 719 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.

Read SEC document
November 20, 2017 Filed Nov 20, 2017 23:43 UTC
Jones James BSVP & Chief Medical Officer
SaleCommon Stock 850 $41.11 $34,942.48
Disclosure

SEC source: 0001209191-17-061873 · doc4.xml · nonDerivative · entry 1

Jones James B · CIK 0001650857 · SVP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,823

F1 · balance_after: Includes 360 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.

Read SEC document
November 17, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 7,857 $0.00 Strike: $25.37 $0.00
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · derivative · entry 6

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,857 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
November 17, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
SaleCommon Stock 7,857 $40.00 $314,280.00
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 4

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,312

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
November 17, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
Exercise / conversionCommon Stock 7,857 $25.37 $199,332.09
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 3

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
Exercise / conversionStock Option (Right to Buy) · Derivative 2,143 $0.00 Strike: $25.37 $0.00
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · derivative · entry 5

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,857

Underlying: Common Stock · 2,143 shares

Expires 2023-03-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and as to the remaining option shares in successive equal monthly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
SaleCommon Stock 2,143 $40.01 $85,741.43
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 2

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,312

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
November 16, 2017 Filed Nov 20, 2017 23:44 UTC
WILLIAMS KRISTENCAO and General Counsel
Exercise / conversionCommon Stock 2,143 $25.37 $54,367.91
Disclosure

SEC source: 0001209191-17-061874 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,455

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
November 15, 2017 Filed Nov 17, 2017 17:15 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 28,885 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001209191-17-061557 · doc4.xml · derivative · entry 6

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,075

Underlying: Common Stock · 28,885 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.

Read SEC document
November 15, 2017 Filed Nov 17, 2017 17:15 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 1,900 $38.97 $74,043.00
Disclosure

SEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 3

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,279

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.85 to $39.10, inclusive.

Read SEC document
November 15, 2017 Filed Nov 17, 2017 17:15 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 56,985 $38.32 $2,183,665.20
Disclosure

SEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,179

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.85 to $38.80, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.

Read SEC document
November 15, 2017 Filed Nov 17, 2017 17:15 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 28,885 $1.61 $46,504.85
Disclosure

SEC source: 0001209191-17-061557 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
November 10, 2017 Filed Nov 14, 2017 01:03 UTC PurchaseCommon Stock 1,000 $41.60 $41,602.50
Disclosure

SEC source: 0001209191-17-060479 · doc4.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,795

Read SEC document
August 22, 2017 Filed Aug 25, 2017 00:30 UTC SaleCommon Stock 1,044 $36.15 $37,740.60
Disclosure

SEC source: 0001209191-17-050231 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,518

Read SEC document
August 15, 2017 Filed Aug 17, 2017 22:56 UTC
WILLIAMS KRISTENCAO and General Counsel
SaleCommon Stock 3,461 $36.75 $127,191.75
Disclosure

SEC source: 0001209191-17-049503 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,312

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
August 15, 2017 Filed Aug 17, 2017 18:55 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 28,885 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001209191-17-049501 · doc4.xml · derivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,810

Underlying: Common Stock · 28,885 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.

Read SEC document
August 15, 2017 Filed Aug 17, 2017 18:55 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 28,885 $36.37 $1,050,547.45
Disclosure

SEC source: 0001209191-17-049501 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,279

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.10 to $36.90, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 15, 2017 Filed Aug 17, 2017 18:55 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 28,885 $1.61 $46,504.85
Disclosure

SEC source: 0001209191-17-049501 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
August 08, 2017 Filed Aug 16, 2017 20:43 UTC PurchaseCommon Stock 100 $37.13 $3,713.16
Disclosure

SEC source: 0001209191-17-049323 · doc4.xml · nonDerivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100

Read SEC document
July 24, 2017 Filed Jul 26, 2017 17:28 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001209191-17-046347 · doc4.xml · derivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,960

Underlying: Common Stock · 15,000 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.

Read SEC document
July 24, 2017 Filed Jul 26, 2017 17:28 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 15,000 $1.61 $24,150.00
Disclosure

SEC source: 0001209191-17-046347 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 220 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017.

Read SEC document
June 23, 2017 Filed Jun 27, 2017 20:22 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001209191-17-042059 · doc4.xml · derivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,960

Underlying: Common Stock · 15,000 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested as to 50% of the option shares on February 2, 2011, 19,378 option shares vested on February 3, 2011, and the remaining option shares vested in successive monthly installments for the subsequent 19 months.

Read SEC document
June 23, 2017 Filed Jun 27, 2017 20:22 UTC
STACK DAVID MDirector · CEO and Chairman
Exercise / conversionCommon Stock 15,000 $1.61 $24,150.00
Disclosure

SEC source: 0001209191-17-042059 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:08 UTC
Weiland Robert J.Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 9,000 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040685 · doc4.xml · derivative · entry 2

Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,000

Underlying: Common Stock · 9,000 shares

Expires 2027-06-14

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:08 UTC
Weiland Robert J.Chief Commercial Officer
GrantCommon Stock 4,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040685 · doc4.xml · nonDerivative · entry 1

Weiland Robert J. · CIK 0001670648 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,864

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

F2 · balance_after: Includes 364 shares of common stock acquired under the issuer's employee stock purchase plan in December 2016.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:06 UTC
Scranton RichardChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040683 · doc4.xml · derivative · entry 2

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:06 UTC
Scranton RichardChief Scientific Officer
GrantCommon Stock 8,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040683 · doc4.xml · nonDerivative · entry 1

Scranton Richard · CIK 0001709330 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,593

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:12 UTC GrantStock Option (Right to Buy) · Derivative 8,144 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040688 · doc4.xml · derivative · entry 1

Froimson Mark · CIK 0001709050 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,144

Underlying: Common Stock · 8,144 shares

Expires 2027-06-14

F1 · derivative.exercise_date: The options vest in 36 equal successive monthly installments over the 36-month period following the date of grant, subject to the reporting person's continued service as a director.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:01 UTC
Braunstein ScottSVP, Strategy & Corp. Dev.
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040677 · doc4.xml · derivative · entry 3

Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2027-06-14

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:01 UTC
Braunstein ScottSVP, Strategy & Corp. Dev.
GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040677 · doc4.xml · nonDerivative · entry 1

Braunstein Scott · CIK 0001643875 · SVP, Strategy & Corp. Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,982

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:04 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040679 · doc4.xml · derivative · entry 2

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 17,500 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:04 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantCommon Stock 8,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040679 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,750

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:13 UTC GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040689 · doc4.xml · derivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:13 UTC GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040689 · doc4.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,845

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:10 UTC
WILLIAMS KRISTENCAO and General Counsel
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040686 · doc4.xml · derivative · entry 2

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:10 UTC
WILLIAMS KRISTENCAO and General Counsel
GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040686 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · CAO and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,773

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:16 UTC GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040692 · doc4.xml · derivative · entry 2

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:16 UTC GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040692 · doc4.xml · nonDerivative · entry 1

LONGENECKER JOHN P PHD · CIK 0001288231 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,145

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:18 UTC GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040694 · doc4.xml · derivative · entry 2

WINGER DENNIS L · CIK 0001222645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:18 UTC GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040694 · doc4.xml · nonDerivative · entry 1

WINGER DENNIS L · CIK 0001222645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,490

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:07 UTC
STACK DAVID MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 81,000 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040684 · doc4.xml · derivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 81,000

Underlying: Common Stock · 81,000 shares

Expires 2027-06-14

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 14, 2017 Filed Jun 16, 2017 20:07 UTC
STACK DAVID MDirector · CEO and Chairman
GrantCommon Stock 40,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040684 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,059

F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2018, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:17 UTC
PACE GARY WDirector
GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040693 · doc4.xml · derivative · entry 2

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:17 UTC
PACE GARY WDirector
GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040693 · doc4.xml · nonDerivative · entry 1

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,537

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:14 UTC GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040690 · doc4.xml · derivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:14 UTC GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040690 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,562

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:11 UTC
Brege LauraDirector
GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040687 · doc4.xml · derivative · entry 2

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:11 UTC
Brege LauraDirector
GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040687 · doc4.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,845

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:15 UTC GrantStock Option (Right to Buy) · Derivative 2,714 $0.00 Strike: $44.20 $0.00
Disclosure

SEC source: 0001209191-17-040691 · doc4.xml · derivative · entry 2

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,714

Underlying: Common Stock · 2,714 shares

Expires 2027-06-14

F2 · derivative.exercise_date: The stock option vests and becomes exercisable on the first anniversary of the grant date, provided that the reporting person remains in continuous service with the issuer through the vesting date.

Read SEC document
June 14, 2017 Filed Jun 17, 2017 00:15 UTC GrantCommon Stock 1,357 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-040691 · doc4.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,795

F1 · shares: Represents restricted stock units that vest on June 3, 2018, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.